BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25829376)

  • 1. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.
    Colizzi M; Iyegbe C; Powell J; Ursini G; Porcelli A; Bonvino A; Taurisano P; Romano R; Masellis R; Blasi G; Morgan C; Aitchison K; Mondelli V; Luzi S; Kolliakou A; David A; Murray RM; Bertolino A; Di Forti M
    Schizophr Bull; 2015 Sep; 41(5):1171-82. PubMed ID: 25829376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance.
    Bertolino A; Taurisano P; Pisciotta NM; Blasi G; Fazio L; Romano R; Gelao B; Lo Bianco L; Lozupone M; Di Giorgio A; Caforio G; Sambataro F; Niccoli-Asabella A; Papp A; Ursini G; Sinibaldi L; Popolizio T; Sadee W; Rubini G
    PLoS One; 2010 Feb; 5(2):e9348. PubMed ID: 20179754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2.
    Taurisano P; Romano R; Mancini M; Giorgio AD; Antonucci LA; Fazio L; Rampino A; Quarto T; Gelao B; Porcelli A; Papazacharias A; Ursini G; Caforio G; Masellis R; Niccoli-Asabella A; Todarello O; Popolizio T; Rubini G; Blasi G; Bertolino A
    Front Behav Neurosci; 2014; 8():235. PubMed ID: 25071490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory.
    Di Giorgio A; Smith RM; Fazio L; D'Ambrosio E; Gelao B; Tomasicchio A; Selvaggi P; Taurisano P; Quarto T; Masellis R; Rampino A; Caforio G; Popolizio T; Blasi G; Sadee W; Bertolino A
    PLoS One; 2014; 9(5):e95997. PubMed ID: 24819610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics.
    Blasi G; Selvaggi P; Fazio L; Antonucci LA; Taurisano P; Masellis R; Romano R; Mancini M; Zhang F; Caforio G; Popolizio T; Apud J; Weinberger DR; Bertolino A
    Neuropsychopharmacology; 2015 Jun; 40(7):1600-8. PubMed ID: 25563748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.
    Trotta A; Iyegbe C; Yiend J; Dazzan P; David AS; Pariante C; Mondelli V; Colizzi M; Murray RM; Di Forti M; Fisher HL
    Schizophr Res; 2019 Mar; 205():51-57. PubMed ID: 29653893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample.
    Soler J; Arias B; Moya J; Ibáñez MI; Ortet G; Fañanás L; Fatjó-Vilas M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():174-180. PubMed ID: 30118824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment.
    Tan HY; Chen AG; Kolachana B; Apud JA; Mattay VS; Callicott JH; Chen Q; Weinberger DR
    Brain; 2012 May; 135(Pt 5):1436-45. PubMed ID: 22525159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
    Zhang JP; Robinson DG; Gallego JA; John M; Yu J; Addington J; Tohen M; Kane JM; Malhotra AK; Lencz T
    Schizophr Bull; 2015 Nov; 41(6):1248-55. PubMed ID: 26320194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine.
    Gelao B; Fazio L; Selvaggi P; Di Giorgio A; Taurisano P; Quarto T; Romano R; Porcelli A; Mancini M; Masellis R; Ursini G; De Simeis G; Caforio G; Ferranti L; Lo Bianco L; Rampino A; Todarello O; Popolizio T; Blasi G; Bertolino A
    Psychopharmacology (Berl); 2014 Jun; 231(11):2361-70. PubMed ID: 24424781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans.
    Blasi G; Lo Bianco L; Taurisano P; Gelao B; Romano R; Fazio L; Papazacharias A; Di Giorgio A; Caforio G; Rampino A; Masellis R; Papp A; Ursini G; Sinibaldi L; Popolizio T; Sadee W; Bertolino A
    J Neurosci; 2009 Nov; 29(47):14812-9. PubMed ID: 19940176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese.
    Zheng C; Shen Y; Xu Q
    Neurosci Lett; 2012 Jun; 518(1):41-4. PubMed ID: 22569179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
    Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
    Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples.
    Cohen OS; Weickert TW; Hess JL; Paish LM; McCoy SY; Rothmond DA; Galletly C; Liu D; Weinberg DD; Huang XF; Xu Q; Shen Y; Zhang D; Yue W; Yan J; Wang L; Lu T; He L; Shi Y; Xu M; Che R; Tang W; Chen CH; Chang WH; Hwu HG; Liu CM; Liu YL; Wen CC; Fann CS; Chang CC; Kanazawa T; Middleton FA; Duncan TM; Faraone SV; Weickert CS; Tsuang MT; Glatt SJ
    Mol Psychiatry; 2016 Jul; 21(7):975-82. PubMed ID: 26347318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis-induced psychosis-like experiences are associated with high schizotypy.
    Barkus EJ; Stirling J; Hopkins RS; Lewis S
    Psychopathology; 2006; 39(4):175-8. PubMed ID: 16636640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in psychosis gene ZNF804A is associated with a refined schizotypy phenotype but not neurocognitive performance in a large young male population.
    Stefanis NC; Hatzimanolis A; Avramopoulos D; Smyrnis N; Evdokimidis I; Stefanis CN; Weinberger DR; Straub RE
    Schizophr Bull; 2013 Nov; 39(6):1252-60. PubMed ID: 23155182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.
    Xu H; Kellendonk CB; Simpson EH; Keilp JG; Bruder GE; Polan HJ; Kandel ER; Gilliam TC
    Schizophr Res; 2007 Feb; 90(1-3):104-7. PubMed ID: 17113268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizotypal traits and cognitive performance in siblings of patients with psychosis.
    Moreno-Samaniego L; Gaviria AM; Vilella E; Valero J; Labad A
    Psychiatry Res; 2017 Dec; 258():551-556. PubMed ID: 28958455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.